Healthcare Roundup – Inovio to begin Phase 1/2 trial of COVID-19 DNA vaccine, Roche’s severe COVID-19 test scores FDA approval Life Science
Technology Roundup – Why isn’t Facebook using Oversight Board for Trump posts? Amazon in early talks to buy 5% stake in Bharti Technology
Healthcare Roundup – Novavax secures source for COVID-19 vaccine adjuvant, Pfizer announces publication of successful abrocitinib study in atopic dermatitis Life Science
Technology Roundup – U.S. launches probe into foreign digital taxes, Amazon adds to aircraft fleet Technology
Healthcare Roundup – FDA OKs emergency use of Philips monitors for COVID-19 use, AgeX Therapeutics +12% on ESI 053 deal for COVID-19 Life Science
Technology Roundup – Wells Fargo sees big upside in Microsoft, Online retail stocks continue to sizzle Technology
Healthcare Roundup – FDA OKs emergency use of Siemens COVID-19 blood test, Short regimen of Gilead’s remdesivir beats standard-of-care in COVID-19 study Life Science
Technology Roundup – Amazon rally expected to extend as online dominates, WarnerMedia names new chief technology officer Technology
Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China Life Science
Technology Roundup – Pair of U.S.-listed China ADRs to list shares in Hong Kong, Trump vs. Twitter war escalates further Technology
Technology Roundup – Trump signs executive order targeting social media, Cisco nearing $1B deal for ThousandEyes Technology
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites Life Science
